Projections were for low single digit growth year on year. Let's see if we can hit our first outlook and build on that.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025